Skip to main content
. 2024 Nov 4;19:153. doi: 10.1186/s13020-024-01025-6

Table 2.

The comparison of the outcomes between two groups

SXD group (n = 53) Placebo group (n = 48) P value
Diarrhea
 Yes 14 (26.42) 25 (52.08) 0.0081a
 No 39 (73.58) 23 (47.92)
No. of chemo cycles with diarrhea
 0 (%) 39 (73.58) 23 (47.92) 0.0278a
 1 (%) 8 (15.09) 16 (33.33)
 2 (%) 6 (11.32) 9 (18.75)
Degree of diarrhea
 0 (%) 39 (73.58) 23 (47.92) 0.0097b
 1 (%) 8 (15.09) 11 (22.92)
 2 (%) 3 (5.66) 13 (27.08)
 3 (%) 3 (5.66) 1 (2.08)
 4 (%) 0 (0.00) 0 (0.00)
 5 (%) 0 (0.00) 0 (0.00)
Antidiarrheal medication
 Yes (%) 6 (11.32) 19 (39.58) 0.0010a
 No (%) 47 (88.68) 29 (60.42)
First occurrence time of diarrhea (day)
 Mean 5.29 3.48 0.1615b
 Median 6 3
Duration of diarrhea (day)
 Mean 7.83 11.11 0.5909b
 Median 7 7
Degree of neutropenia
 0 (%) 30 (56.60) 19 (39.58) 0.0465b
 1 (%) 11 (20.75) 10 (20.83)
 2 (%) 7 (13.21) 9 (18.75)
 3 (%) 5 (9.43) 10 (20.83)
 4 (%) 0 (0.00) 0 (0.00)

aChi-square test

bWilcoxon rank sum test